2023
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Weimer M, Herring A, Kawasaki S, Meyer M, Kleykamp B, Ramsey K. ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids. Journal Of Addiction Medicine 2023, 17: 632-639. PMID: 37934520, DOI: 10.1097/adm.0000000000001202.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnalgesics, OpioidBuprenorphineCentral Nervous System StimulantsHumansOpioid-Related DisordersProspective StudiesConceptsHigh potency synthetic opioidsOpioid use disorderBuprenorphine initiationBuprenorphine treatmentTreatment needsUse disordersClinical considerationsExpert consensusSynthetic opioidsTreatment of OUDProspective researchOpioid agonist treatmentLong-term treatmentDrug supplyPatients' treatment needsOpioid withdrawalBuprenorphine doseOUD treatmentAgonist treatmentDosing frequencyClinical questionsFrontline cliniciansClinical practiceTreatment settingsIndividualized strategies
2011
A Novel Approach to Increase Residents' Involvement in Reporting Adverse Events
Scott DR, Weimer M, English C, Shaker L, Ward W, Choi D, Cedfeldt A, Girard D. A Novel Approach to Increase Residents' Involvement in Reporting Adverse Events. Academic Medicine 2011, 86: 742-746. PMID: 21512369, DOI: 10.1097/acm.0b013e318217e12a.Peer-Reviewed Original ResearchMeSH KeywordsHumansInternship and ResidencyLinear ModelsOregonPhysician Incentive PlansProgram EvaluationProspective StudiesQuality ImprovementRisk Management